Market News AIOpen the app

ADRX stock news · ADARx Pharmaceuticals

Stories about ADARx Pharmaceuticals (ADRX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ADRX

Follow ADARx Pharmaceuticals (ADRX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ADRX
Free on the App Store and Google Play, or on the web.
  1. Nov 12, 2026, 5:37 PM ET · Deal

    ADARx Pharmaceuticals made $2.2 million from partnerships last quarter, up from last year, and shared updates on its trials.

    Good for ADRX

    ADARx's collaboration revenue rose to $2.2 million from $1.6 million, and its $602.5 million raise supports cash into 2030. Trial progress and FDA status make this favorable.